New Zealand markets close in 2 hours 45 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
130.85-1.21 (-0.92%)
At close: 04:00PM EDT
130.36 -0.49 (-0.37%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 54.78B
Enterprise value 45.61B
Trailing P/E 4.05
Forward P/E 5.45
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.62
Price/book (mrq)3.21
Enterprise value/revenue 2.02
Enterprise value/EBITDA 2.75

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 3-27.12%
S&P500 52-week change 3-5.29%
52-week high 3497.49
52-week low 3119.01
50-day moving average 3153.57
200-day moving average 3247.10

Share statistics

Avg vol (3-month) 36.89M
Avg vol (10-day) 35.84M
Shares outstanding 5397.76M
Implied shares outstanding 6N/A
Float 8332.7M
% held by insiders 19.43%
% held by institutions 164.17%
Shares short (12 May 2022) 417.06M
Short ratio (12 May 2022) 42.64
Short % of float (12 May 2022) 45.75%
Short % of shares outstanding (12 May 2022) 44.29%
Shares short (prior month 13 Apr 2022) 416.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 64.77%
Operating margin (ttm)71.93%

Management effectiveness

Return on assets (ttm)50.42%
Return on equity (ttm)139.99%

Income statement

Revenue (ttm)22.6B
Revenue per share (ttm)56.01
Quarterly revenue growth (yoy)213.20%
Gross profit (ttm)13.86B
Net income avi to common (ttm)14.64B
Diluted EPS (ttm)34.02
Quarterly earnings growth (yoy)199.50%

Balance sheet

Total cash (mrq)10.12B
Total cash per share (mrq)25.43
Total debt (mrq)947M
Total debt/equity (mrq)5.55
Current ratio (mrq)1.77
Book value per share (mrq)42.69

Cash flow statement

Operating cash flow (ttm)13.41B
Levered free cash flow (ttm)8.59B